Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3904243

O=C(Nc1ncc(Br)s1)c1ccncc1NC(=O)c1ccc(N2CCCC2)cc1OC1CCNCC1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.37
PIM3 Q86V86 3/20 0.37
PIM2 Q9P1W9 3/20 0.37
ATR Q13535 1/20 0.36
IRAK4 Q9NWZ3 8/20 0.36
GPR6 P46095 2/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
IRAK1 P51617 1/20 0.35
UTS2R Q9UKP6 1/20 0.35
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
DYRK1A Q13627 1/20 0.35
BCL9 O00512 1/20 0.35
CTNNB1 P35222 1/20 0.35
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286962 0.95 ATR (0.39) PIM1PIM3PIM2ATRIRAK4
Trifluoroacetic Acid SCHEMBL3903120 0.89 PTGDR (0.40) PIM1PIM3PIM2ATRIRAK4
Trifluoroacetic Acid SCHEMBL3902573 0.85 PIM1 (0.41) PIM1PIM3PIM2IRAK4GPR6
SCHEMBL3903799 0.84 TXK (0.39) GPR6DYRK1APDE4APDE4BPDE4C
Trifluoroacetic Acid SCHEMBL3898752 0.84 F10 (0.44) PIM1PIM3PIM2ATRIRAK4
SCHEMBL8287160 0.83 PTGDR (0.42) PIM1PIM3PIM2ATRIRAK4
SCHEMBL8285039 0.80 GRM5 (0.43) PIM1PIM3PIM2IRAK4GPR6
SCHEMBL3907747 0.80 GPR6 (0.34) PIM3PIM2GPR6PDE4APDE4B
SCHEMBL3910283 0.79 MEN1 (0.48) PIM1PIM3PIM2ATRIRAK4
SCHEMBL3903409 0.78 F10 (0.48) ATRIRAK4IRAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511066-B2 Antithrombotic aromatic ethers ELI LILLY AND COMPANY (US) 2009-03-31 US disclosed
US-20070027185-A1 Antithrombotic aromatic ethers ELILILLY AND COMPANY (US) 2007-02-01 US disclosed
EP-1670783-A2 ANTITHROMBOTIC AROMATIC ETHERS ELI LILLY AND COMPANY (US) 2006-06-21 EP disclosed
WO-2005049604-A2 ANTITHROMBOTIC AROMATIC ETHERS ELI LILLY AND COMPANY (US) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027185-A1 Antithrombotic aromatic ethers F2, F11, TFPI PIM1 1670/4885PIM3 3149/4885PIM2 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.